PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jurbhealthspringer.comThis journalToc AlertsSubmit OnlineOpen ChoiceThis journal
 
J Urban Health. 2003 June; 80(2): 189–200.
PMCID: PMC3456279

Heroin overdose: Research and evidence-based intervention

Abstract

Drug overdose is a major cause of premature death and morbidity among heroin users. This article examines recent research into heroin overdose to inform interventions that will reduce the rate of overdose death. The demographic characteristics of overdose cases are discussed, including factors associated with overdose: polydrug use, drug purity, drug tolerance, routes of administration, and suicide. Responses by heroin users at overdoses are also examined. Potential interventions to reduce the rate of overdose and overdose-related morbidity are examined in light of the emerging data in this field.

Full Text

The Full Text of this article is available as a PDF (81K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Fugelstad A, Annell A, Rajs J, Angren G. Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981–1992. Acta Psychiatr Scand. 1997;96:169–175. [PubMed]
2. Goldstein A, Herrara J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend. 1995;40:139–150. doi: 10.1016/0376-8716(95)01205-2. [PubMed] [Cross Ref]
3. Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22 year follow-up. Addiction. 1994;89:1299–1308. doi: 10.1111/j.1360-0443.1994.tb03309.x. [PubMed] [Cross Ref]
4. Quaglio G, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P. Study of 2708 heroin-related deaths in north-eastern Italy 1985–98 to establish main causes of death. Addiction. 2001;96:1127–1137. doi: 10.1046/j.1360-0443.2001.96811276.x. [PubMed] [Cross Ref]
5. Sanchez-Carbonell X, Seus L. Ten year survival analysis of a cohort of heroin addicts in Catalonia: the EMETYST project. Addiction. 2000;95:941–948. doi: 10.1046/j.1360-0443.2000.95694110.x. [PubMed] [Cross Ref]
6. Darke S, Zador D. Fatal heroin overdose: a review. Addiction. 1996;91:1765–1772. doi: 10.1111/j.1360-0443.1996.tb03800.x. [PubMed] [Cross Ref]
7. Sporer K. Acute heroin overdose. Ann Int Med. 1999;130:584–590. [PubMed]
8. Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction. 2001;96:1113–1125. doi: 10.1046/j.1360-0443.2001.96811135.x. [PubMed] [Cross Ref]
9. Centers for Disease Control Heroin overdose deaths—Multnomah County, Oregon, 1993–1999. MMWR Morb Mortal Wkly Rep. 2000;49:633–636. [PubMed]
10. Centers for Disease Control Unintentional opiate overdose deaths—Kings County, Washington, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49:636–640. [PubMed]
11. Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001;26:453–460. doi: 10.1016/S0306-4603(00)00115-5. [PubMed] [Cross Ref]
12. O’Driscoll PT, McGough J, Hagan H, Thiede H, Critchlow C, Russell AE. Predictors of accidental fatal drug overdose among a cohort of injection drug users. Am J Public Health. 2001;26:984–987.
13. Hall W, Degenhardt L, Lynskey M. Trends in opioid overdose and suicide mortality in young adults in Australia 1964–1997. Med J Aust. 1999;171:34–37. [PubMed]
14. Bennett G, Higgins D. Accidental overdose among injecting drug users in Dorset, UK. Addiction. 1999;94:1179–1190. doi: 10.1046/j.1360-0443.1999.94811798.x. [PubMed] [Cross Ref]
15. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia. I. Prevalence and correlates of non-fatal overdose. Addiction. 1996;91:405–411. doi: 10.1111/j.1360-0443.1996.tb02289.x. [PubMed] [Cross Ref]
16. Darke S, Ross J. Overdose risk perceptions and behaviours among heroin users in Sydney, Australia. Eur Addict Res. 1997;3:87–92.
17. Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313:402–402. [PMC free article] [PubMed]
18. McGregor C, Darke S, Christie P, Ali R. Experience of non-fatal overdose among heroin users in Adelaide: circumstances and risk perception. Addiction. 1998;93:701–711. doi: 10.1046/j.1360-0443.1998.9357016.x. [PubMed] [Cross Ref]
19. Swift W, Maher L, Sunjic S. Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction. 1999;94:71–82. doi: 10.1046/j.1360-0443.1999.941714.x. [PubMed] [Cross Ref]
20. Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction. 2000;95:687–695. doi: 10.1046/j.1360-0443.2000.9556874.x. [PubMed] [Cross Ref]
21. Cherubin C, McCusker J, Baden M, Kavaler F, Amsel Z. The epidemiology of death in narcotic addicts. Am J Epidemiol. 1972;96:11–22. [PubMed]
22. Darke S, Ross J, Zador D, Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992–1996. Drug Alcohol Depend. 2000;60:141–150. doi: 10.1016/S0376-8716(99)00147-7. [PubMed] [Cross Ref]
23. Frischer M, Bloor M, Goldberg D, Clark J, Green S, McKegany N. Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health. 1993;47:59–63. doi: 10.1136/jech.47.1.59. [PMC free article] [PubMed] [Cross Ref]
24. Hall W, Darke S. Trends in opiate overdose deaths in Australia, 1979–1995. Drug Alcohol Depend. 1998;52:71–77. doi: 10.1016/S0376-8716(98)00044-1. [PubMed] [Cross Ref]
25. McGregor C, Ali R, Lokan R, Christie P, Darke S. Accidental fatalities among heroin users in South Australia, 1994–1997: toxicological findings and circumstances of death. Addict Res. 2002;26:335–346. doi: 10.1080/1606635021000010261. [Cross Ref]
26. Zador D, Sunjic S, Darke S. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust. 1996;164:204–207. [PubMed]
27. Harlow KC. Patterns of rates of mortality from narcotics and cocaine overdose in Texas, 1976–1987. Public Health Rep. 1990;195:455–462. [PMC free article] [PubMed]
28. Ruttenber AJ, Luke JL. Heroin-related deaths: new epidemiologic insights. Science. 1984;226:14–20. [PubMed]
29. Caplehorn JRM, Dalton SYN, Cluff MC, Petrenas AM. Retention in methadone maintenance and heroin addicts’ risk of death. Addiction. 1994;89:203–207. doi: 10.1111/j.1360-0443.1994.tb00879.x. [PubMed] [Cross Ref]
30. Davoli M, Perucci CA, Forastiere F, et al. Risk factors for overdose mortality: a case control study within a cohort of intravenous drug users. Int J Epidemiol. 1993;22:273–277. [PubMed]
31. Fugelstad A, Rajs J, DeVerdier MG. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction. 1995;90:711–716. doi: 10.1111/j.1360-0443.1995.tb02209.x. [PubMed] [Cross Ref]
32. Stewart D, Gossop M, Marsden J. Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS) J Subst Abuse Treat. 2002;22:1–9. doi: 10.1016/S0740-5472(01)00206-9. [PubMed] [Cross Ref]
33. Goldberger BA, Cone EJ, Grant TM, Caplan YH, Levine BS, Smialek JE. Disposition of heroin and its metabolites in heroin related deaths. J Anal Toxicol. 1994;18:22–28. [PubMed]
34. Monforte JR. Some observations concerning blood morphine concentrations in narcotic addicts. J Forensic Sci. 1977;22:718–724. [PubMed]
35. Risser D, Honigschnabl S, Stichenwirth M, et al. Drug-related emergencies and drug-related deaths in Vienna, 1995–1997. Drug Alcohol Depend. 2001;61:307–313. doi: 10.1016/S0376-8716(00)00150-2. [PubMed] [Cross Ref]
36. Steentoft A, Worm K, Christenson H. Morphine concentrations in autopsy material from fatal cases after intake of morphine and/or heroin. J Forensic Sci Soc. 1988;28:87–94. doi: 10.1016/S0015-7368(88)72812-1. [PubMed] [Cross Ref]
37. Gutierrez-Cebollada J, Torre R, Ortuno J, Garces J, Cami J. Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend. 1994;35:169–174. doi: 10.1016/0376-8716(94)90124-4. [PubMed] [Cross Ref]
38. Ruttenber AJ, Kalter HO, Santinga P. The role of ethanol abuse in the etiology of heroin-related death. J Forensic Sci. 1990;35:891–900. [PubMed]
39. Caplehorn J. Risk factors for non-HIV-related deaths among methadone maintenance patients. Eur Addict Res. 1996;2:49–52.
40. Richards RG, Reed D, Cravey RH. Death from intravenously administered narcotics: a study of 114 cases. J Forensic Sci. 1976;21:467–482. [PubMed]
41. Darke S, Ross J. The use of antidepressants among injecting drug users in Sydney, Australia. Addiction. 2000;95:407–417. doi: 10.1046/j.1360-0443.2000.95340711.x. [PubMed] [Cross Ref]
42. Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend. 1999;54:155–161. doi: 10.1016/S0376-8716(98)00159-8. [PubMed] [Cross Ref]
43. Desmond DP, Maddux JF, Trevino A. Street heroin potency and deaths from overdose in San Antonio. Am J Drug Alcohol Abuse. 1978;5:39–49. [PubMed]
44. Risser D, Uhl A, Stichenwirth M, et al. Quality of heroin and heroin-related deaths from 1987 to 1995 in Vienna, Austria. Addiction. 2000;95:375–382. doi: 10.1046/j.1360-0443.2000.9533758.x. [PubMed] [Cross Ref]
45. Coomber R. How often does the adulteration/dilution of heroin actually occur? An analysis of 228 “street” heroin samples across the UK (1995–96) and discussion of monitoring policy. Int J Durg Policy. 1997;8:178–186.
46. Coomber R. The cutting of heroin in the United States in the 1990s. J Drug Issues. 1999;29:17–36.
47. Maher L, Swift W, Dawson M. Heroin purity and composition in Sydney, Australia. Drug Alcohol Rev. 2001;20:439–448. doi: 10.1080/09595230120092698. [Cross Ref]
48. Darke S, Sunjic S, Zador D, Prolov T. A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia. Drug Alcohol Depend. 1997;47:45–53. doi: 10.1016/S0376-8716(97)00070-7. [PubMed] [Cross Ref]
49. Kintz P, Mangin P, Lugnier AA, Chaumont AJ. Toxicological data after heroin overdose. Hum Toxicol. 1989;8:487–489. doi: 10.1177/096032718900800609. [PubMed] [Cross Ref]
50. Darke S, Hall W, Kaye S, Ross J, Duflou J. Hair morphine concentrations of fatal heroin overdose cases and living heroin users. Addiction. 2002;97:977–984. doi: 10.1046/j.1360-0443.2002.00148.x. [PubMed] [Cross Ref]
51. Tagliaro F, Debattisti Z, Smith FP, Marigo M. Death from heroin overdose: findings from hair analysis. Lancet. 1998;351:1923–1925. doi: 10.1016/S0140-6736(97)10101-5. [PubMed] [Cross Ref]
52. Kronstrand R, Grundin R, Jonsson J. Incidence of opiates, amphetamines, and cocaine in hair and blood in fatal cases of heroin overdose. Forensic Sci Int. 1998;92:29–38. doi: 10.1016/S0379-0738(98)00003-6. [PubMed] [Cross Ref]
53. Darke S, Kaye S, Finlay-Jones R. Drug use and injection risk-taking among prison methadone maintenance patients. Addiction. 1998;93:1169–1175. doi: 10.1046/j.1360-0443.1998.93811695.x. [PubMed] [Cross Ref]
54. Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998;316:426–428. [PMC free article] [PubMed]
55. Seymour A, Oliver JS, Black M. Drug-related deaths among recently released prisoners in the Strathelyde region of Scotland. J Forensic Sci. 2000;45:649–654. [PubMed]
56. Strang J, Griffiths P, Powis B, Gossop M. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am J Addict. 1999;8:148–160. doi: 10.1080/105504999305956. [PubMed] [Cross Ref]
57. Neaigus A, Miller M, Friedman S, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96:847–860. doi: 10.1046/j.1360-0443.2001.9668476.x. [PubMed] [Cross Ref]
58. Perez-Jimenez JP, Robert MS. Transitions in the route of heroin use. Eur Addict Res. 1997;3:93–98. doi: 10.1159/000259157. [Cross Ref]
59. Darke S, Ross J. Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992–1996. Addiction. 2000;95:596–599.
60. Dinwiddie SH, Reich T, Cloninger CR. Psychiatric comorbidity and suicidality among intravenous drug users. J Clin Psychiatry. 1992;53:364–369. [PubMed]
61. Darke S, Ross J. Poly drug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 1997;48:135–141. doi: 10.1016/S0376-8716(97)00117-8. [PubMed] [Cross Ref]
62. Kosten TR, Rounsaville BJ. Suicidality among opioid addicts: a 2.5 year follow-up. Am J Drug Alcohol Abuse. 1998;14:357–369. [PubMed]
63. Hulse GK, English DR, Milne E, Holman CDJ. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999;94:221–229. doi: 10.1046/j.1360-0443.1999.9422216.x. [PubMed] [Cross Ref]
64. Neale J. Suicidal intent in non-fatal illicit drug overdose. Addiction. 2000;95:85–93. doi: 10.1046/j.1360-0443.2000.951859.x. [PubMed] [Cross Ref]
65. Rossow I, Lauritzen G. Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts. Addiction. 1999;94:209–219. doi: 10.1046/j.1360-0443.1999.9422095.x. [PubMed] [Cross Ref]
66. Darke S, Ross J. The relationship between suicide and overdose among methadone maintenance patients in Sydney, Australia. Addiction. 2001;96:1443–1453. doi: 10.1046/j.1360-0443.2001.961014438.x. [PubMed] [Cross Ref]
67. Kjelsberg E, Winther M, Dahl AA. Overdose deaths in young substance abusers: accidents or hidden suicides. Acta Psychiatr Scand. 1995;91:236–242. [PubMed]
68. Darke S, Ross J. Suicide among heroin users: rates, risk factors and methods. Addiction. 2002;97:1383–1394. doi: 10.1046/j.1360-0443.2002.00214.x. [PubMed] [Cross Ref]
69. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia. II. Responses to overdose. Addiction. 1996;91:413–417. doi: 10.1111/j.1360-0443.1996.tb02290.x. [PubMed] [Cross Ref]
70. Strang J, Best D, Man L, Noble A, Gossop M. Peer-initiated overdose resuscitation: fellow drug users could be mobilised to implement resuscitation. Int J Drug Policy. 2000;11:437–445. doi: 10.1016/S0955-3959(00)00070-0. [PubMed] [Cross Ref]
71. Manning FJ, Ingraham LH, Derouin EM, Vaughn MS, Kukura FC, St Michel GR. Drug “overdoses” among US soldiers in Europe, 1978–1979. II. Psychological autopsies following deaths and near-deaths. Int J Addict. 1983;18:153–156. [PubMed]
72. Garriot JC, Sturner WQ. Morphine concentrations and survival periods in acute heroin fatalities. N Engl J Med. 1973;289:1276–1278. doi: 10.1056/NEJM197312132892404. [PubMed] [Cross Ref]
73. Nakamura GR. Toxicological assessments in acute heroin fatalities. Clin Toxicol. 1978;13:75–87. doi: 10.3109/15563657808988229. [PubMed] [Cross Ref]
74. Bammer G, Sengoz A. Non-fatal heroin overdoses. Med J Aust. 1994;161:572–573. [PubMed]
75. McGregor C, Ali R, Christie P, Darke S. Overdose among heroin users: evaluation of an intervention in South Australia. Addict Res. 2001;9:481–501.
76. Darke S, Hall W. The distribution of naloxone to heroin users. Addiction. 1997;92:1195–1199. doi: 10.1111/j.1360-0443.1997.tb03681.x. [PubMed] [Cross Ref]
77. Lenton S, Hargreaves K. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Med J Aust. 2000;173:260–263. [PubMed]
78. Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: is there a case for takehome naloxone? BMJ. 1996;312:1435–1435. [PMC free article] [PubMed]
79. Hunt N, Griffiths P, Southwell M, Stillwell G, Strang J. Proventing and curtailing injecting drug use: a review of opportunities for developing and delivering “route transition interventions” Drug Alcohol Rev. 1999;18:441–445. doi: 10.1080/09595239996310. [Cross Ref]
80. Dolan K, Kimber J, Fry C, Fitzgerald J, McDonald D, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev. 2000;337–346.
81. Kemmesies UE. The Open Drug Scene and the Safe Injection Rooms Offers in Frankfurt am Main 1995. Frankfurt, Germany: Stadt Frankfurt/Dezernat Frauen und Gesundheit; 1999.
82. Poschadel S, Hoger R, Schnitzler J, Schreckenberg D. Evaluation der Arbeit der Drogenkonsumraume in der Bundesrepublik Deutschland. Bochum, Germany: ZEUS GmbH; 2002.
83. Ronco C, Spuhler G, Coda P, Schopfer R. Evaluation for alley-rooms I, II and II in Basel. Soc Prev Med. 1996;S58–S68.
84. Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription. Lancet. 2001;358:1417–1420. doi: 10.1016/S0140-6736(01)06529-1. [PubMed] [Cross Ref]
85. Hall W. Assessing the Population-Level Impact of the Swiss Model of Heroin Prescribing. Sydney, Australia: University of New South Wales, Sydney; 1999.
86. Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction. 2002;97:963–967. doi: 10.1046/j.1360-0443.2002.00132.x. [PubMed] [Cross Ref]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine